StevenEliotComeMD

Oncology • Boston, MA

Breast Cancer, Hematologic Oncology

BIDMC/ DF-Harvard CC

Join to view full profile

Dr. Come is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Come's full profile

Already have an account?

Office
330 Brookline Ave
Boston, MA 02215
Phone+1 617-667-4599

Education & Training

Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1972 - 1974
Harvard Medical SchoolClass of 1972
National Institutes of Health Clinical CenterFellowship, Medical Oncology

Certifications & Licensure

MA State Medical License 1976 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors for Cancer Castle Connolly, 2005-2020
America's Top Doctors Castle Connolly, 2002-2020
Boston Magazine Castle Connolly, 2008-2019
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Boston Herald Castle Connolly, 2005
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Efficacy and Safety of 500mg of Fulvestrant Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 2
Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer Start of enrollment: 2011 Oct 01
Active, not recruiting
Phase 2
The Young Women's Breast Cancer Study Start of enrollment: 2006 Nov 01
Active, not recruiting
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26
Completed
Phase 2
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer Start of enrollment: 2014 Jan 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Financial Difficulty Over Time in Young Adults With Breast Cancer.
Sara P Myers, Yue Zheng, Kate Dibble, Elizabeth A Mittendorf, Tari A King
JAMA Network Open. 2024-11-04
Second primary non-breast cancers in young breast cancer survivors.
Bessie X Zhang, Kristen D Brantley, Shoshana M Rosenberg, Gregory J Kirkner, Laura C Collins
Breast Cancer Research and Treatment. 2024-10-01
1 citations
Breastfeeding experiences among young breast cancer survivors: A survey study.
Tal Sella, Kimia Sorouri, Shoshana M Rosenberg, Maggie Loucks, Gregory Kirkner
Cancer. 2024-09-29

Other

Patterns of relapse and long-term complications of therapy in breast cancer survivors
Come SE, Hurria A
http://www.uptodate.com/contents/patterns-of-relapse-and-long-term-complications-of-therapy-in-breas
UpToDate, Wolters Kluwer Health - 2013-01-09

Grant Support

Biology And Treatment Of Brca1-Associated And Sporadic Basal-Like CancersNational Cancer Institute2008–2009

Professional Memberships

American Society of Clinical Oncology - ASCO
Member